{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:33:57Z","timestamp":1793205237921,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bone.2023.116884","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T04:19:52Z","timestamp":1692332392000},"page":"116884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["AGEs accumulation with vascular complications, glycemic control and metabolic syndrome: A narrative review"],"prefix":"10.1016","volume":"176","author":[{"given":"Rimesh","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2023.116884_bb0005","article-title":"Incidence and risk factors for dysglycaemia in Asian-Indians: a 10-year population-based prospective cohort study","author":"Gupta","year":"2021","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.bone.2023.116884_bb0010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12272-019-01130-3","article-title":"Recent advances in the pathogenesis of microvascular complications in diabetes","volume":"42","author":"Park","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bone.2023.116884_bb0015","doi-asserted-by":"crossref","DOI":"10.4172\/2168-9652.1000246","article-title":"Role of advanced glycation end products (AGE) in health and disease: an overview","volume":"07","author":"Vadakedath","year":"2018","journal-title":"Biochem. Physiol. Open Access."},{"key":"10.1016\/j.bone.2023.116884_bb0020","doi-asserted-by":"crossref","first-page":"1002710","DOI":"10.3389\/fmolb.2022.1002710","article-title":"Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications","volume":"9","author":"Mengstie","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bone.2023.116884_bb0025","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1016\/S0021-9258(20)89449-6","article-title":"Immunochemical approach to characterize advanced glycation end products of the Maillard reaction","volume":"266","author":"Horiuchi","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2023.116884_bb0030","doi-asserted-by":"crossref","first-page":"18492","DOI":"10.1074\/jbc.274.26.18492","article-title":"Methylglyoxal modification of protein","volume":"274","author":"Oya","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2023.116884_bb0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1196\/annals.1333.025","article-title":"Ketosis leads to increased methylglyoxal production on the Atkins diet","volume":"1043","author":"Beisswenger","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2023.116884_bb0040","doi-asserted-by":"crossref","first-page":"024","DOI":"10.17352\/2455-8583.000019","article-title":"Role of advanced glycation end products in the progression of diabetes mellitus","volume":"4","author":"Xu","year":"2017","journal-title":"Glob. J. Obes. Diabetes Metab. Syndr."},{"key":"10.1016\/j.bone.2023.116884_bb0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8227(98)00074-6","article-title":"Increased serum levels of advanced glycation end-products and diabetic complications","volume":"41","author":"Ono","year":"1998","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bone.2023.116884_bb0050","doi-asserted-by":"crossref","DOI":"10.15761\/IFNM.1000267","article-title":"Role of advanced glycation end products (AGEs) and its receptor (RAGE)-mediated diabetic vascular complications","volume":"6","author":"Chawla","year":"2019","journal-title":"Integr. Food Nutr. Metab."},{"key":"10.1016\/j.bone.2023.116884_bb0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/dc14-1435","article-title":"Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function","volume":"38","author":"Kajikawa","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bone.2023.116884_bb0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gene.2013.03.062","article-title":"Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G\/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy","volume":"521","author":"Ng","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.bone.2023.116884_bb0065","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3390\/nu14153086","article-title":"Advanced glycation end products and their effect on vascular complications in type 2 diabetes mellitus","volume":"14","author":"Lee","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bone.2023.116884_bb0070","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.numecd.2013.04.004","article-title":"AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a \u201cglycoxidation-centric\u201d point of view","volume":"23","author":"Chilelli","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.bone.2023.116884_bb0075","doi-asserted-by":"crossref","first-page":"13316","DOI":"10.1039\/C7CC06624D","article-title":"In situ characterization of advanced glycation end products (AGEs) in collagen and model extracellular matrix by solid state NMR","volume":"53","author":"Li","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bone.2023.116884_bb0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bone.2018.01.028","article-title":"Accumulation of carboxymethyl-lysine (CML) in human cortical bone","volume":"110","author":"Thomas","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2023.116884_bb0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13098-022-00895-w","article-title":"The association between advanced glycation end products (AGEs) and ABC (hemoglobin A1C, blood pressure, and low-density lipoprotein cholesterol) control parameters among patients with type 2 diabetes mellitus","volume":"14","author":"Rezaei","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.bone.2023.116884_bb0090","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.15419\/bmrat.v7i8.623","article-title":"Correlation of serum fluorescence of advanced glycation end products with diabetes duration and glycemic control in type 2 diabetic patients","volume":"7","author":"Ali","year":"2020","journal-title":"Biomed. Res. Ther."},{"key":"10.1016\/j.bone.2023.116884_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111750","article-title":"Novel advances in inhibiting advanced glycation end product formation using natural compounds","volume":"140","author":"Song","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bone.2023.116884_bb0100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/gerona\/glu243","article-title":"Autofluorescence of skin advanced glycation end products: marker of metabolic memory in elderly population","volume":"70","author":"Rajaobelina","year":"2015","journal-title":"J. Gerontol. Ser. A."},{"key":"10.1016\/j.bone.2023.116884_bb0105","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2337\/diabetes.54.11.3103","volume":"54","author":"Genuth","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bone.2023.116884_bb0110","first-page":"523","article-title":"Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats","volume":"150","author":"Stitt","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2023.116884_bb0115","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s001250051221","article-title":"Differential accumulation of advanced glycation end products in the course of diabetic retinopathy","volume":"42","author":"Hammes","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.bone.2023.116884_bb0120","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1006\/bbrc.2001.6312","article-title":"Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes","volume":"290","author":"Yamagishi","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2023.116884_bb0125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1006\/bbrc.1995.2185","article-title":"Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy","volume":"213","author":"Yamagishi","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2023.116884_bb0130","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.3390\/ijms21197413","article-title":"Pericyte-endothelial interactions in the retinal microvasculature","volume":"21","author":"Huang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2023.116884_bb0135","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1167\/iovs.10-5881","article-title":"AGEs and diabetic retinopathy","volume":"51","author":"Stitt","year":"2010","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.bone.2023.116884_bb0140","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1167\/iovs.02-1063","article-title":"The role of advanced glycation end products in retinal microvascular leukostasis","volume":"44","author":"Moore","year":"2003","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.bone.2023.116884_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108880","article-title":"Association of advanced glycation end products with diabetic retinopathy in type 2 diabetes mellitus","volume":"177","author":"Ying","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bone.2023.116884_bb0150","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.4103\/ijo.IJO_1244_21","article-title":"Elevated advanced glycation end products are associated with subfoveal ellipsoid zone disruption in diabetic macular edema","volume":"69","author":"Mishra","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.bone.2023.116884_bb0155","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jdiacomp.2010.06.005","article-title":"Role of advanced glycation end product receptors in the pathogenesis of diabetic retinopathy","volume":"25","author":"Al-Mesallamy","year":"2011","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.bone.2023.116884_bb0160","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/dc07-1755","article-title":"Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications","volume":"31","author":"Gerrits","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bone.2023.116884_bb0165","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/dme.12005","article-title":"Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study: skin autofluorescence and risk of micro- and macrovascular complications","volume":"29","author":"Noordzij","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bone.2023.116884_bb0170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.diabet.2009.11.003","article-title":"Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy","volume":"36","author":"Chabroux","year":"2010","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.bone.2023.116884_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2014.00151","article-title":"Molecular and cellular events mediating glomerular podocyte dysfunction and depletion in diabetes mellitus","volume":"5","author":"Anil Kumar","year":"2014","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bone.2023.116884_bb0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1515\/bmc-2016-0021","article-title":"Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy","volume":"7","author":"Kumar Pasupulati","year":"2016","journal-title":"Biomol. Concepts."},{"key":"10.1016\/j.bone.2023.116884_bb0185","doi-asserted-by":"crossref","first-page":"20309","DOI":"10.1074\/jbc.M202634200","article-title":"Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells","volume":"277","author":"Yamagishi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2023.116884_bb0190","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1523-1755.2003.00752.x","article-title":"Advanced glycation end products inhibit de novo protein synthesis and induce TGF-\u03b2 overexpression in proximal tubular cells","volume":"63","author":"Yamagishi","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2023.116884_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.685447","article-title":"Advanced-glycation end-products induce podocyte injury and contribute to proteinuria","volume":"8","author":"Nishad","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.bone.2023.116884_bb0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.abb.2015.11.003","article-title":"Carboxymethyl lysine induces EMT in podocytes through transcription factor ZEB2: implications for podocyte depletion and proteinuria in diabetes mellitus","volume":"590","author":"Kumar","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bone.2023.116884_bb0205","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.2337\/dc12-2689","article-title":"Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products","volume":"36","author":"Beisswenger","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bone.2023.116884_bb0210","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2337\/dc21-2196","article-title":"Advanced glycation end products predict loss of renal function and high-risk chronic kidney disease in type 2 diabetes","volume":"45","author":"Koska","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bone.2023.116884_bb0215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.160.1.197","article-title":"Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation endproducts","volume":"160","author":"Vlassara","year":"1984","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bone.2023.116884_bb0220","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s001250050839","article-title":"Localization in human diabetic peripheral nerve of N \u03b5 -carboxymethyllysine-protein adducts, an advanced glycation endproduct","volume":"40","author":"Sugimoto","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.bone.2023.116884_bb0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0035-1558086","article-title":"The mechanisms of inhibition of advanced glycation end products formation through polyphenols in hyperglycemic condition","volume":"82","author":"Khangholi","year":"2015","journal-title":"Planta Med."},{"key":"10.1016\/j.bone.2023.116884_bb0230","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s001250051223","article-title":"Only limited effects of aminoguanidine treatment on peripheral nerve function, (Na +, K+)-ATPase activity and thrombomodulin expression in streptozotocin-induced diabetic rats","volume":"42","author":"Wada","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.bone.2023.116884_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.891442","article-title":"Advanced glycation end-products are associated with diabetic neuropathy in young adults with type 1 diabetes","volume":"13","author":"Al-Saoudi","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bone.2023.116884_bb0240","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/a-1831-0991","article-title":"Correlation between skin advanced glycation end products and cardiac autonomic neuropathy among subjects with type 2 diabetes mellitus","volume":"130","author":"Papachristou","year":"2022","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.bone.2023.116884_bb0245","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00125-005-1828-x","article-title":"Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy","volume":"48","author":"Meerwaldt","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.bone.2023.116884_bb0250","first-page":"1233","article-title":"Levels of soluble advanced glycation end product-receptors and other soluble serum markers as indicators of diabetic neuropathy in the foot","volume":"59","author":"El-Mesallamy","year":"2011","journal-title":"J. Investig. Med. Off. Publ. Am. Fed. Clin. Res."},{"key":"10.1016\/j.bone.2023.116884_bb0255","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.2337\/dc12-2661","article-title":"The DCCT\/EDIC research group, the association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT\/EDIC study","volume":"36","author":"Orchard","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bone.2023.116884_bb0260","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1046\/j.1432-1033.2002.03017.x","article-title":"Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles","volume":"270","author":"Knott","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bone.2023.116884_bb0265","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3400\/avd.ra.18-00070","article-title":"Role of hyperglycemia-induced advanced glycation end product (AGE) accumulation in atherosclerosis","volume":"11","author":"Yamagishi","year":"2018","journal-title":"Ann. Vasc. Dis."},{"key":"10.1016\/j.bone.2023.116884_bb0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2337\/diab.41.2.S67","article-title":"Lipoprotein glycation and its metabolic consequences","volume":"41","author":"Lyons","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.bone.2023.116884_bb0275","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2478\/v10011-009-0006-y","article-title":"The effect of hyperglycemia and oxidative stress on the development and progress of vascular complications in type 2 diabetes","volume":"28","author":"\u010colak","year":"2009","journal-title":"J. Med. Biochem."},{"key":"10.1016\/j.bone.2023.116884_bb0280","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCRESAHA.117.306666","article-title":"Differential role of an NF-\u03baB transcriptional response element in endothelial versus intimal cell VCAM-1 expression","volume":"117","author":"Milstone","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2023.116884_bb0285","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s13300-022-01285-1","article-title":"Association between the tissue and circulating advanced glycation end-products and the micro- and macrovascular complications in type 1 diabetes: the DIABAGE study","volume":"13","author":"Diallo","year":"2022","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.bone.2023.116884_bb0290","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dme.13651","article-title":"Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus","volume":"35","author":"Yozgatli","year":"2018","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bone.2023.116884_bb0295","doi-asserted-by":"crossref","first-page":"E1369","DOI":"10.1210\/jc.2013-1068","article-title":"Plasma levels of advanced glycation endproducts N \u03f5 -(carboxymethyl)lysine, N \u03f5 -(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM Studies","volume":"98","author":"Hanssen","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2023.116884_bb0300","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/advances\/nmab072","article-title":"Circulating advanced glycation end products and their soluble receptors in relation to all-cause and cardiovascular mortality: a systematic review and meta-analysis of prospective observational studies","volume":"12","author":"Sharifi-Zahabi","year":"2021","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.bone.2023.116884_bb0305","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41574-022-00707-1","article-title":"Bone fragility in type 2 diabetes mellitus: a lot left to explore","volume":"18","author":"Pal","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bone.2023.116884_bb0310","doi-asserted-by":"crossref","DOI":"10.1097\/MED.0000000000000640","article-title":"Bone health in diabetes: Indian perspective","author":"Pal","year":"2021","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes. Publish Ahead of Print"},{"key":"10.1016\/j.bone.2023.116884_bb0315","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bone.2023.116884_bb0320","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11914-022-00755-6","article-title":"Meta-analysis of diabetes mellitus-associated differences in bone structure assessed by high-resolution peripheral quantitative computed tomography","volume":"20","author":"Walle","year":"2022","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2023.116884_bb0325","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bone.2017.01.037","article-title":"Women with type 2 diabetes mellitus have lower cortical porosity of the proximal femoral shaft using low-resolution CT than nondiabetic women, and increasing glucose is associated with reduced cortical porosity","volume":"97","author":"Osima","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2023.116884_bb0330","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/jbmr.3711","article-title":"Altered tissue composition, microarchitecture, and mechanical performance in cancellous bone from men with type 2 diabetes mellitus","volume":"34","author":"Hunt","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2023.116884_bb0335","doi-asserted-by":"crossref","first-page":"e2271","DOI":"10.1210\/clinem\/dgab027","article-title":"Investigation of mechanical, material, and compositional determinants of human trabecular bone quality in type 2 diabetes","volume":"106","author":"Sihota","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2023.116884_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035047","article-title":"Heterogeneous glycation of cancellous bone and its association with bone quality and fragility","volume":"7","author":"Karim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2023.116884_bb0345","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/jbmr.4153","article-title":"Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with type 2 diabetes","volume":"35","author":"Piccoli","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2023.116884_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257955","article-title":"Can fingernail quality predict bone damage in Type 2 diabetes mellitus? A pilot study","volume":"16","author":"Sihota","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2023.116884_bb0355","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S2213-8587(22)00103-6","article-title":"Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study","volume":"10","author":"Schwartz","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bone.2023.116884_bb0360","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11914-016-0332-1","article-title":"Advanced glycation end products, diabetes, and bone strength","volume":"14","author":"Yamamoto","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2023.116884_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117046","article-title":"Insulin-like growth factor 1, glycation and bone fragility: implications for fracture resistance of bone","volume":"10","author":"Sroga","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2023.116884_bb0370","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/jbmr.4186","article-title":"Bone tissue composition in postmenopausal women varies with glycemic control from normal glucose tolerance to type 2 diabetes mellitus","volume":"36","author":"Hunt","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2023.116884_bb0375","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2013.11.023","article-title":"Mineral particle size in children with osteogenesis imperfecta type I is not increased independently of specific collagen mutations","volume":"60","author":"Fratzl-Zelman","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.bone.2023.116884_bb0380","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10379","article-title":"Development of HFD -fed\/low dose STZ treated female Sprague Dawley rat model to investigate diabetic bone fragility at different organization levels","author":"Sihota","year":"2020","journal-title":"JBMR Plus."},{"key":"10.1016\/j.bone.2023.116884_bb0385","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jbmr.4757","article-title":"Increased advanced glycation endproducts, stiffness, and hardness in iliac crest bone from postmenopausal women with type 2 diabetes mellitus on insulin","volume":"38","author":"Lekkala","year":"2023","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2023.116884_bb0390","article-title":"Accumulation of fluorescent advanced glycation end products and carboxymethyl-lysine in human cortical and trabecular bone","volume":"17","author":"Vaidya","year":"2022","journal-title":"Bone Rep."},{"key":"10.1016\/j.bone.2023.116884_bb0395","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jbmr.4466","article-title":"Greater carboxy-methyl-lysine is associated with increased fracture risk in type 2 diabetes","volume":"37","author":"Dhaliwal","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2023.116884_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmbbm.2023.105731","article-title":"Effect of ribose incubation on physical, chemical, and mechanical properties of human cortical bone","volume":"140","author":"Unal","year":"2023","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.bone.2023.116884_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmbbm.2022.105619","article-title":"An investigation on the effects of in vitro induced advanced glycation end-products on cortical bone fracture mechanics at fall-related loading rates","volume":"138","author":"Britton","year":"2023","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.bone.2023.116884_bb0410","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4103\/ijem.IJEM_585_17","article-title":"Nonalcoholic fatty liver disease and Type 2 diabetes mellitus","volume":"22","author":"Dharmalingam","year":"2018","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2023.116884_bb0415","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.bone.2023.116884_bb0420","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.3390\/ijms20205037","article-title":"Development and progression of non-alcoholic fatty liver disease: the role of advanced glycation end products","volume":"20","author":"Fernando","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2023.116884_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/7867852","article-title":"Advanced glycation end products induce obesity and hepatosteatosis in CD-1 wild-type mice","volume":"2016","author":"Sayej","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bone.2023.116884_bb0430","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jhep.2013.11.033","article-title":"Dietary glycotoxins exacerbate progression of experimental fatty liver disease","volume":"60","author":"Leung","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bone.2023.116884_bb0435","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.metabol.2018.01.023","article-title":"Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults","volume":"83","author":"Palma-Duran","year":"2018","journal-title":"Metabolism."},{"key":"10.1016\/j.bone.2023.116884_bb0440","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/nu11020462","article-title":"The relevance of toxic AGEs (TAGE) cytotoxicity to NASH pathogenesis: a mini-review","volume":"11","author":"Sakasai-Sakai","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.bone.2023.116884_bb0445","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.3390\/nu13103370","article-title":"Advanced glycation end-products in common non-infectious liver diseases: systematic review and meta-analysis","volume":"13","author":"Litwinowicz","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bone.2023.116884_bb0450","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.3748\/wjg.v27.i29.4913","article-title":"Advanced glycation end product: a potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study","volume":"27","author":"da Silva Pereira","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bone.2023.116884_bb0455","doi-asserted-by":"crossref","first-page":"bqz006","DOI":"10.1210\/endocr\/bqz006","article-title":"Advanced glycation end products: building on the concept of the \u201ccommon soil\u201d in metabolic disease","volume":"161","author":"Ruiz","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2023.116884_bb0460","doi-asserted-by":"crossref","first-page":"15888","DOI":"10.1073\/pnas.1205847109","article-title":"Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1","volume":"109","author":"Cai","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bone.2023.116884_bb0465","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3945\/ajcn.115.125427","article-title":"Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial","volume":"103","author":"de Courten","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bone.2023.116884_bb0470","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/09637486.2015.1137889","article-title":"Dietary consumption of advanced glycation end products and risk of metabolic syndrome","volume":"67","author":"Angoorani","year":"2016","journal-title":"Int. J. Food Sci. Nutr."},{"key":"10.1016\/j.bone.2023.116884_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128293","article-title":"Association between advanced glycation end products and impaired fasting glucose: results from the SALIA study","volume":"10","author":"Teichert","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2023.116884_bb0480","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/advances\/nmaa150","article-title":"The impact of low advanced glycation end products diet on metabolic risk factors: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Sohouli","year":"2021","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.bone.2023.116884_bb0485","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/en.2014-1381","article-title":"AGEs-RAGE system down-regulates Sirt1 through the ubiquitin-proteasome pathway to promote FN and TGF-\u03b21 expression in male rat glomerular mesangial cells","volume":"156","author":"Huang","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2023.116884_bb0490","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1196\/annals.1447.011","article-title":"Induction of apoptosis of \u03b2 cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus","volume":"1150","author":"Lim","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2023.116884_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018782","article-title":"AGEs decrease insulin synthesis in pancreatic \u03b2-cell by repressing Pdx-1 protein expression at the post-translational level","volume":"6","author":"Shu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2023.116884_bb0500","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00394-019-02129-8","article-title":"Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults","volume":"59","author":"Cordova","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.bone.2023.116884_bb0505","doi-asserted-by":"crossref","first-page":"E1003","DOI":"10.1152\/ajpendo.90377.2008","article-title":"Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet","volume":"296","author":"Posey","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2023.116884_bb0510","doi-asserted-by":"crossref","first-page":"1900934","DOI":"10.1002\/mnfr.201900934","article-title":"The role of dietary advanced glycation end products in metabolic dysfunction","volume":"65","author":"Sergi","year":"2021","journal-title":"Mol. Nutr. Food Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822300217X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822300217X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:06:37Z","timestamp":1757613997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632822300217X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":102,"alternative-id":["S875632822300217X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2023.116884","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AGEs accumulation with vascular complications, glycemic control and metabolic syndrome: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2023.116884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116884"}}